Key result
Extracorporeal membranous oxygenator (ECMO) use during TAVR offers a promising option for cardiac support rescue in cases of intraoperative hemodynamic instability.
Why the study?
What are the indications, rationale, and advantages of using extracorporeal membranous oxygenator (ECMO) in transcatheter aortic valve replacement (TAVR) procedures?
What are the indications, rationale, and advantages of using extracorporeal membranous oxygenator (ECMO) in transcatheter aortic valve replacement (TAVR) procedures?
This review highlights the potential role of ECMO as a rescue or prophylactic cardiac support strategy during TAVR procedures.
The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.
No takes yet. Share an insight, caveat, or question.
Makdisi et al. (2016) conducted a review in Aortic stenosis undergoing transcatheter aortic valve replacement. Extracorporeal membranous oxygenator (ECMO) was evaluated. Extracorporeal membranous oxygenator (ECMO) use during TAVR offers a promising option for cardiac support rescue in cases of intraoperative hemodynamic instability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: